Morning Headlines 5/16/22
PatientIQ, a patient outcomes data and insights vendor, raises $20 million in a Series B funding round.
Amwell Announces Results for First Quarter 2022
Amwell announces Q1 results: revenue up 11%, EPS –$0.26 versus –$0.16, missing analyst expectations for both.
A randomized clinical trial finds that remote monitoring and financial incentives had no impact on readmissions or deaths among discharged heart failure patients.
As one of the Y2K army of programmers, I can assure you there would have been major outages and errors…